ProBiotix Health Plc (AQU:PBX)
London
· Delayed Price · Currency is GBP · Price in GBX 6.50
0.00 (0.00%)
At close: Dec 5, 2025
ProBiotix Health Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 2.22 | 1.88 | 1.67 | 1.12 | 1.1 | 0.82 | Upgrade
|
| Revenue Growth (YoY) | 4.42% | 12.55% | 49.19% | 1.93% | 33.98% | 123.60% | Upgrade
|
| Cost of Revenue | 1.04 | 0.89 | 0.8 | 0.48 | 0.55 | 0.31 | Upgrade
|
| Gross Profit | 1.18 | 1 | 0.87 | 0.64 | 0.55 | 0.51 | Upgrade
|
| Selling, General & Admin | 1.85 | 1.78 | 1.58 | 0.72 | 0.45 | 0.46 | Upgrade
|
| Operating Expenses | 1.92 | 1.85 | 1.63 | 0.76 | 0.45 | 0.46 | Upgrade
|
| Operating Income | -0.74 | -0.85 | -0.76 | -0.12 | 0.11 | 0.05 | Upgrade
|
| Interest Expense | - | - | - | 0.01 | -0.06 | -0.06 | Upgrade
|
| Interest & Investment Income | - | - | - | 0.06 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0.17 | - | - | Upgrade
|
| Pretax Income | -0.74 | -0.85 | -0.76 | -0.22 | 0.04 | -0.01 | Upgrade
|
| Income Tax Expense | -0 | -0.01 | -0.02 | 0.01 | 0.01 | - | Upgrade
|
| Net Income | -0.74 | -0.85 | -0.75 | -0.23 | 0.04 | -0.01 | Upgrade
|
| Net Income to Common | -0.74 | -0.85 | -0.75 | -0.23 | 0.04 | -0.01 | Upgrade
|
| Shares Outstanding (Basic) | 146 | 133 | 122 | 90 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 146 | 133 | 122 | 90 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 19.85% | 9.70% | 34.59% | 90298.56% | - | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.00 | 0.36 | -0.13 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.00 | 0.36 | -0.13 | Upgrade
|
| Free Cash Flow | -0.78 | -1.07 | -0.24 | -0.62 | - | 0 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.00 | -0.01 | - | 0.01 | Upgrade
|
| Gross Margin | 53.17% | 52.95% | 52.12% | 57.10% | 50.44% | 61.90% | Upgrade
|
| Operating Margin | -33.18% | -45.25% | -45.55% | -11.01% | 9.62% | 5.62% | Upgrade
|
| Profit Margin | -33.14% | -44.98% | -44.65% | -20.66% | 3.30% | -1.62% | Upgrade
|
| Free Cash Flow Margin | -35.12% | -56.82% | -14.23% | -55.03% | - | 0.10% | Upgrade
|
| EBITDA | -0.69 | -0.8 | -0.71 | -0.09 | - | - | Upgrade
|
| EBITDA Margin | -30.84% | -42.43% | -42.38% | -8.18% | - | - | Upgrade
|
| D&A For EBITDA | 0.05 | 0.05 | 0.05 | 0.03 | - | - | Upgrade
|
| EBIT | -0.74 | -0.85 | -0.76 | -0.12 | 0.11 | 0.05 | Upgrade
|
| EBIT Margin | -33.18% | -45.25% | -45.55% | -11.01% | 9.62% | 5.62% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 15.17% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.